XSHE
000661
Market cap5.61bUSD
Jul 14, Last price
100.67CNY
1D
0.59%
1Q
4.06%
Jan 2017
-8.81%
Name
Changchun High & New Tech Industry Inc
Chart & Performance
Profile
Changchun High-Tech Industries (Group) Inc., together with its subsidiaries, manufactures and sells biopharmaceuticals and proprietary Chinese medicines in China. It also engages in real estate development, property management, and real estate leasing services. The company was formerly known as Changchun High & New Technology Industry (Group) Inc. Changchun High-Tech Industries (Group) Inc. was founded in 1993 and is based in Changchun, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 14,566,040 15.35% | 12,627,189 17.50% | |||||||
Cost of revenue | 6,883,885 | 6,898,171 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 7,682,155 | 5,729,018 | |||||||
NOPBT Margin | 52.74% | 45.37% | |||||||
Operating Taxes | 734,452 | 709,241 | |||||||
Tax Rate | 9.56% | 12.38% | |||||||
NOPAT | 6,947,703 | 5,019,777 | |||||||
Net income | 4,532,484 9.47% | 4,140,524 10.19% | |||||||
Dividends | (404,666) | (321,798) | |||||||
Dividend yield | 0.68% | 0.47% | |||||||
Proceeds from repurchase of equity | (218,563) | (87,773) | |||||||
BB yield | 0.37% | 0.13% | |||||||
Debt | |||||||||
Debt current | 144,472 | 318,528 | |||||||
Long-term debt | 712,476 | 1,174,349 | |||||||
Deferred revenue | 120,543 | 135,124 | |||||||
Other long-term liabilities | 120,716 | 307 | |||||||
Net debt | (7,912,092) | (5,323,870) | |||||||
Cash flow | |||||||||
Cash from operating activities | 5,111,442 | 2,826,408 | |||||||
CAPEX | (2,096,800) | ||||||||
Cash from investing activities | (2,289,724) | ||||||||
Cash from financing activities | (739,961) | ||||||||
FCF | 4,912,092 | 2,369,058 | |||||||
Balance | |||||||||
Cash | 7,593,774 | 5,578,513 | |||||||
Long term investments | 1,175,266 | 1,238,234 | |||||||
Excess cash | 8,040,738 | 6,185,388 | |||||||
Stockholders' equity | 20,505,196 | 18,148,596 | |||||||
Invested Capital | 17,926,258 | 16,005,826 | |||||||
ROIC | 40.95% | 35.55% | |||||||
ROCE | 29.45% | 25.65% | |||||||
EV | |||||||||
Common stock shares outstanding | 409,809 | 407,532 | |||||||
Price | 145.80 -12.41% | 166.45 -38.67% | |||||||
Market cap | 59,750,099 -11.92% | 67,833,679 -39.00% | |||||||
EV | 54,795,330 | 65,266,500 | |||||||
EBITDA | 8,231,040 | 6,164,207 | |||||||
EV/EBITDA | 6.66 | 10.59 | |||||||
Interest | 38,130 | 43,745 | |||||||
Interest/NOPBT | 0.50% | 0.76% |